Drug Patent Expirations in April 2010

Drug Patent Expirations in April 2010

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
HYZAAR Merck hydrochlorothiazide; losartan potassium 5,153,197*PED Apr 6, 2010
IPLEX Insmed mecasermin rinfabate recombinant 5,200,509 Apr 6, 2010
COZAAR Merck losartan potassium 5,153,197*PED Apr 6, 2010
DUODOTE Meridian Medcl atropine; pralidoxime chloride 5,092,843 Apr 12, 2010
EMBEDA Alpharma King morphine sulfate; naltrexone hydrochloride 5,202,128 Apr 13, 2010
KADIAN Actavis Elizabeth morphine sulfate 5,202,128 Apr 13, 2010
MUSE Vivus alprostadil 5,773,020 Apr 25, 2010
FLOMAX Boehringer Ingelheim tamsulosin hydrochloride 4,703,063*PED Apr 27, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com


Leave a Reply